Adenovirus-mediated human interleukin 24 (MDA-7/IL-24) selectively suppresses proliferation and induces apoptosis in keloid fibroblasts

Annals of Plastic Surgery

Volumn 66, Issue 6, 2011, Pages 660-666

  Liang, Jie ^a   Huang, Ru Lin ^a   Huang, Qian ^a   Peng, Zhi ^a   Zhang, Pei Hua ^a   Wu, Zhi Xian ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; keloid; MDA 7 IL 24; proliferation

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24;

ADENOVIRUS; ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; KELOID; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN;

ADENOVIRIDAE; ADOLESCENT; ADULT; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; INTERLEUKINS; KELOID; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TRANSFECTION; YOUNG ADULT;

EID: 79958038790     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181e05039     Document Type: Article

References (46)

1. Peacock EE Jr, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J. 1970;63:755-760.
2. Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117:286-300. (Pubitemid 44391579)
3. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63-67.
4. Phan TT, Lim IJ, Aalami O, et al. Smad3 signaling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol. 2005;207:232-242. (Pubitemid 41404154)
5. Ong CT, Khoo YT, Tan EK, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol. 2007;211:95-108. (Pubitemid 46092034)
6. Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98-105. (Pubitemid 46005666)
7. Sadick H, Herberger A, Riedel K, et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. Int J Mol Med. 2008;22:55-60.
8. Desmoulière A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146:56-66.
9. Sayah DN, Soo C, Shaw WW, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res. 1999;87:209-216. (Pubitemid 30000588)
10. Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 1995;11:2477-2486. (Pubitemid 26023815)
11. Huang EY, Madireddi MT, Gopalkrishnan RV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene. 2001;20:7051-7063. (Pubitemid 33052197)
12. Chaiken IM, Williams WV. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design. Trends Biotechnol. 1996;14:369-375. (Pubitemid 26328672)
13. Dumoutier L, Leemans C, Lejeune D, et al. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol. 2001;167:3545-3549. (Pubitemid 32910793)
14. Wang M, Tan Z, Zhang R, et al. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem. 2002;277:7341-7347. (Pubitemid 34953129)
15. Gupta P, Su ZZ, Lebedeva IV, et al. Mda-7/IL-24: multifunctional cancer specific apoptosis-inducing cytokine. Pharmacol Ther. 2006;111:596-628. (Pubitemid 44118431)
16. Fisher PB, Gopalkrishnan RV, Chada S, et al. Mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther. 2003;2: S23-S37.
17. Oida Y, Gopalan B, Miyahara R, et al. Inhibition of nuclear factor-κB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation. Mol Cancer Ther. 2007;6:1440-1449. (Pubitemid 46712008)
18. Zhang KJ, Wang YG, Cao X, et al. Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus. Hum Gene Ther. 2009;20:1-13.
19. Su ZZ, Lebedeva IV, Sarkar D, et al. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene. 2006;25:2339-2348.
20. Sarkar D, Lebedeva IV, Su ZZ, et al. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res. 2007;67:5434-5442. (Pubitemid 46997284)
21. Sarkar D, Su ZZ, Vozhilla N, et al. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc Natl Acad Sci USA. 2005;102:14034-14039. (Pubitemid 41377698)
22. Zheng M, Bocangel D, Doneske B, et al. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol Immunother. 2007;56:205-215. (Pubitemid 44833094)
23. Emdad L, Lebedeva IV, Su ZZ, et al. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells. Mol Cancer Ther. 2007;6:2985-2994. (Pubitemid 350206777)
24. Luo J, Xia Q, Zhang R, et al. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene. Clin Cancer Res. 2008;14:2450-2457. (Pubitemid 351551080)
25. Su ZZ, Lebedeva IV, Sarkar D, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53 independent manner. Oncogene. 2003;22:1164-1180. (Pubitemid 36363380)
26. Yacoub A, Mitchell C, Lebedeva IV, et al. Mda-7 (IL-24) inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther. 2003;2:347-353.
27. Park MA, Yacoub A, Sarkar D, et al. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy. 2008;4:513-515. (Pubitemid 351705149)
28. Gopalan B, Litvak A, Sharma S, et al. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res. 2005;65:3017-3024. (Pubitemid 40524577)
29. Gopalan B, Shanker M, Chada S, et al. MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo. Mol Cancer. 2007;6:11.
30. Wang CM, Hyakusok H, Zhang QX, et al. Pathological genomics of keloid fibroblastic cells [in Chinese]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2005;21:299-301.
31. Li JC, Liang J, Luo SJ, et al. Expression and clinical significance of interleukin-24 mRNA in keloid. J Clin Rehabil Tissue Eng Res. 2007;11:6432-6435. (Pubitemid 47433224)
32. Liang J, Li JC, Luo SJ, et al. The mRNA expression of interleukin-24 gene in hypertrophic scars. J Guangdong Med Coll. 2007;25:123-125.
33. Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol. 1989;9:1642-1650. (Pubitemid 19095205)
34. Liang J, He HT, Peng Z, et al. The construction and identification of recombinant adenovirus vector of hIL-24. China Prac Med. 2007;2:46-47.
35. Sarkar D, Su ZZ, Lebedeva IV, et al. Mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA. 2002;99:10054-10059. (Pubitemid 34831171)
36. Lebedeva IV, Su ZZ, Chang Y, et al. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene. 2002;21:708-718. (Pubitemid 34146283)
37. Chada S, Mhashilkar AM, Ramesh R, et al. Bystander activity of Admda7: human MDA-7 protein kills melanoma cells via an IL-20 receptordependent but STAT3-independent mechanism. Mol Ther. 2004;10:1085-1095. (Pubitemid 39625252)
38. Sauane M, Gupta P, Lebedeva IV, et al. N-Glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity. Cancer Res. 2006;66:11869-11877. (Pubitemid 46094199)
39. Sainz-Perez A, Gary-Gouy H, Portier A, et al. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia. 2006;20:498-504. (Pubitemid 43291750)
40. Pataer A, Vorburger SA, Chada S, et al. Melanoma differentiation- associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther. 2005;11:717-723. (Pubitemid 40567976)
41. Qian W, Liu J, Tong Y, et al. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia. 2008;22:361-369. (Pubitemid 351250541)
42. Yacoub A, Gupta P, Park MA, et al. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Mol Cancer Ther. 2008;7:314-329. (Pubitemid 351302525)
43. Leath CA III, Kataram M, Bhagavatula P, et al. Infectivity enhanced adenoviralmediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecol Oncol. 2004;94:352-362. (Pubitemid 39024537)
44. Zerbini LF, Czibere A, Wang Y, et al. A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal antiinflammatory drug-induced apoptosis and growth arrest of cancer cells. Cancer Res. 2006;66:11922-11931. (Pubitemid 46094205)
45. Andoh A, Shioya M, Nishida A, et al. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J Immunol. 2009;183:687-695.
46. Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929-979. (Pubitemid 38680445)